 |
End Product Testing
Every batch of products we produce must pass sterility testing to verify and validate the absence of microbiological contamination. In order to demonstrate stability and sterility of Compounded Sterile Preparations (CSP’s) for a period of time greater than that described in USP <797>, the CSP must maintain chemical and physical integrity and protection and, protection against microbiological contamination (USP <1150>). Verification of product integrity and quality may include quantitative and/or qualitative testing as well as personnel requirements (USP <1163>).
|
 |
Quality Procedures
We pride ourselves on our extensive Continuous Quality Assessment and Improvement Program (CQAIP) that continues to expand. It covers many United States Pharmacopeia monograph to include:
(1) USP <71> - Sterility Tests
(2) USP <797> - Pharmaceutical Compounding – Sterile Preparations
(3) USP <1150> - Pharmaceutical Stability
(4) USP <1163> - Quality Assurance in Pharmaceutical Compounding
(5) USP <1075> - Good Compounding Practices
(6) General Notices – Preservation, Packaging, Storage, and Labeling
|